GlassScriptPhysician profile
Christopher S Connelly
NPI 1457321978
$430.90
in general payments reported to CMS, 2019-2025
13 companies · $56.47 in 2025
The $56.47 reported for 2025 was less than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.87 · 2022: $49.46 · 2023: $308 · 2025: $56.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $72.03 | 2022-2023 | Tysabri, Vumerity |
| Amgen INC. | $56.47 | 2025 | Uplizna |
| Abbvie INC. | $46.74 | 2023 | Qulipta, Ubrelvy |
| Celgene Corporation | $43.18 | 2023 | Zeposia |
| Tg Therapeutics, INC. | $37.68 | 2023 | |
| Pfizer INC. | $34.15 | 2023 | |
| Lilly USA, LLC | $32.28 | 2022-2023 | Emgality, Amyvid |
| Xeris Pharmaceuticals, INC. | $27.73 | 2023 | Keveyis |
| Genentech USA, INC. | $17.92 | 2023 | Ocrevus |
| Sunovion Pharmaceuticals INC. | $16.87 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.97 | 2023 | Austedo Xr |
| Biohaven Pharmaceutical Holding Company LTD. | $15.60 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.28 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Connelly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.